Paradigm shift in clinical trial regulations in India

India has the potential to contribute meaningfully to global clinical drug development. A critical enabler to achieve this potential is a balanced, predictable, and scientifically robust regulation involving clinical studies. In the past few years, the country's regulatory milieu has witnessed...

Full description

Saved in:
Bibliographic Details
Main Authors: Sandeep Lahiry, Rajasree Sinha, Shouvik Choudhury, Ayan Mukherjee, Suparna Chatterjee
Format: Article
Language:English
Published: SAGE Publishing 2018-01-01
Series:Indian Journal of Rheumatology
Subjects:
Online Access:http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2018;volume=13;issue=1;spage=51;epage=55;aulast=Lahiry
Tags: Add Tag
No Tags, Be the first to tag this record!